Lenovo Chairman and CEO, Yuanqing Yang, to Keynote CES 2026 at Sphere
The event at Sphere, which will showcase content created exclusively for Lenovo by Sphere Studios, Sphere's in-house immersive content studio, marks the second consecutive year that a CES keynote will be delivered at the cutting-edge venue. Tech World comes as Lenovo and Sphere enter a multi-year global partnership, making Lenovo An Official Technology Partner
of Sphere Studios.
Tech World @ CES will explore how Lenovo is defining the future through the fusion of AI, devices, infrastructure, and services. As a global technology partner for both Formula 1® and the FIFA World Cup 26™, the audience will see not only how Lenovo innovation will help individuals and businesses, but also how the company plans to use AI and its full portfolio of technologies to change the game for sports fans in the years to come.
"Over the past decade, Tech World has become Lenovo's key platform to reveal our vision, showcase our innovation, and launch our most exciting products, solutions, and partnerships," said Yuanqing Yang, Chairman and CEO, Lenovo. "Now, set against the backdrop of CES 2026, we'll give the audience an exclusive look at how our technology has revolutionized F1, unveil our plans for the first-ever AI-powered FIFA World Cup next summer, and create a hyper-personalized agent-native experience for individuals while unleashing Lenovo Hybrid AI Advantage for enterprise customers. Sphere is the perfect match for Lenovo in Las Vegas, where we will celebrate and share our commitment to delivering smarter AI for all by constantly redefining how technology can engage, inspire, and empower."
Under Yang's leadership, Lenovo has grown from the world's #1 PC manufacturer to a US$69 billion global technology powerhouse serving millions of customers every day in 180 markets and manufacturing in 11 markets across five continents. Yang is passionate about tech advancing broader societal progress, not just business growth. He is the recipient of many awards and industry accolades, including Barron's Best CEOs and the Edison Achievement Award.
"We're thrilled to welcome Lenovo and Yuanqing Yang to the CES keynote stage. CES is where innovators show up, and I look forward to seeing his vision for the technology solving big global challenges come to life at the incredible Sphere," said Gary Shapiro, CEO and Vice Chair, CTA.
As a Fortune Global 500 technology company, Lenovo rethinks the way organizations use hybrid AI to evolve their business. The keynote at Sphere will offer a unique experience that presents Lenovo's story in innovative ways.
"As a venue at the forefront of innovation, Sphere is a powerful platform for visionary brands looking to create transformative events and experiences," said Jennifer Koester, President and COO, Sphere. "We are honored to collaborate with Lenovo not only to help bring their vision to life during this CES Keynote, but also as part of our broader partnership that will leverage Lenovo technology to deliver immersive experiences across all Sphere events."
At CES 2025, Delta used Sphere's immersive capabilities, including its haptic seats, to create a multi-sensory experience for over 8000 attendees.
"Having the first ever CES keynote at Sphere was a huge highlight of our 2025 show," said Kinsey Fabrizio, President, CTA. "We look forward to experiencing how Lenovo will use Sphere to showcase how tech powers all industries."
Don't miss the opportunity to experience a CES keynote in Sphere — an event that will demonstrate how Lenovo is driving progress and reimagining our digital future. The keynote is at 5:00 PM PT on Tuesday, January 6. Information on ticketing and logistics will be available soon.
This event is only open to credentialed CES attendees. Sign up for alerts about CES 2026 registration, opening this fall.
About CES ®:
CES is the most powerful tech event in the world – the proving ground for breakthrough technologies and global innovators. This is where the world's biggest brands do business and meet new partners, and the sharpest innovators hit the stage. Owned and produced by the Consumer Technology Association (CTA) ®, CES features every aspect of the tech sector. CES 2026 takes place Jan. 6-9 in Las Vegas. Learn more at CES.tech and follow CES on social.
About Consumer Technology Association (CTA) ®:
As North America's largest technology trade association, CTA is the tech sector. Our members are the world's leading innovators – from startups to global brands – helping support more than 18 million American jobs. CTA owns and produces CES ® – the most powerful tech event in the world. Find us at CTA.tech. Follow us @CTAtech.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
4 hours ago
- Cision Canada
Cipher Pharmaceuticals Reports Second Quarter 2025 Results, Including Record Revenue
(All figures are presented in U.S. Dollars) Highest single-quarter revenue in the Company's history with total revenue of $13.4 million in Q2 2025 Adjusted EBITDA 1 in Q2 2025 was $7.6 million, an increase of 148% over Q2 2024 Epuris sales volumes grew 14% in the quarter compared to Q2 2024 Natroba TM sales were $7.8 million during the quarter, a sequential increase of 16% over Q1 2025 Strong cash generation with $6.0 million cash from operations in Q2 2025 $15.0 million debt repayment and share repurchases of $2.1 million during Q2 2025 $7.0 million debt repayment subsequent to Q2 2025 MISSISSAUGA, ON, Aug. 7, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher" or the " Company") today announced its financial and operating results for the three and six months ended June 30, 2025. First Quarter 2025 Financial Highlights (All figures in U.S. dollars, compared to Q2 2024, unless otherwise noted) Total revenue was $13.4 million in Q2 2025, an increase of 152% Canadian product portfolio revenue increased by 12% to $4.1 million in Q2 2025, compared to $3.7 million in Q2 2024 Natroba TM provided $7.8 million of incremental product revenue in Q2 2025 Licensing revenue was $1.5 million in Q2 2025, compared to $1.6 million in Q2 2024 Total gross profit from operations increased by 159% to $10.9 million in Q2 2025 Adjusted EBITDA 1 increased 148% to $7.6 million in Q2 2025 Cash balance of $11.3 million at the end of Q2 2025 Management Commentary Craig Mull, Interim CEO, commented:"Cipher has continued its growth during the second quarter of 2025, with quarterly revenue achieving a historical record for the Company, largely contributed to by our U.S. business. The U.S. business, led by Natroba™, continues to exceed our expectations from when we acquired the business almost one year ago, in July 2024. The U.S. business has contributed to a more than doubling of Cipher's total revenue and Adjusted EBITDA 1 compared to the prior year, for both the second quarter and the year-to-date. We look forward to providing further updates on the impact our strategy and activities surrounding the business have on the performance of Natroba™ for the remainder of 2025. Cipher's base business in Canada continues to experience year-over-year growth from Epuris®, with the product realizing revenue growth of 25% for the year-to-date 2025 compared to the same period in 2024, which largely offsets the decline in revenue derived from our licensing portfolio as a result of the competitive pressures faced by our commercial partners for these out-licensed products in the U.S. market." Ryan Mailling, CFO, commented: "In Q2 2025, we had another quarter of strong cash generation, with $6.0 million of cash generated from operations during the quarter. Cash generated in the second quarter, combined with previous cash accumulation, was allocated during the quarter to a $15.0 million repayment on our revolving credit facility, de-levering the business, as well as repurchases of our common shares through our normal course issuer bid ("NCIB"), which returned $2.1 million to our shareholders. After this effective use of available capital, at the end of the second quarter $11.3 million of cash remained on our balance sheet. Accordingly, subsequent to the end of the quarter we further allocated $7.0 million to an additional repayment on our revolving credit facility, resulting in $47.0 million of financing remaining available through the facility, plus a $25.0 million accordion option, which in total is $72.0 million of total potential financing available. We continue to be in an excellent position to execute on growth opportunities." Corporate Highlights On April 29, 2025, Cipher announced its product Natroba TM received preferred step-through status on Medicaid in the state of Illinois, whereby its main product competitor Permethrin 5% was downgraded to non-preferred on the state's preferred drug listing. This move by Illinois Medicaid will require all prescriptions for Permethrin 5% to first 'step-though' Natroba TM representing the treatment of choice in the state. On May 1, 2025, Cipher announced that the Toronto Stock Exchange (the "TSX") had approved the Company's Notice of Intention to Make a Normal Course Issuer Bid under which the Company may purchase for cancellation, from time to time up to May 4, 2026, up to an aggregate of 1,485,260 of its issued and outstanding common shares, being 10% of its public float of 14,852,604 common shares as of April 22, 2025. In accordance with TSX rules, any daily repurchases on the TSX under the NCIB are limited to a maximum of 10,427 common shares, which represents 25% of the average daily trading volume on the TSX of 41,708 for the six months ended March 31, 2025. To facilitate larger repurchases, the Company is entitled to make one weekly block purchase on the TSX that may exceed the daily repurchase restrictions. On May 8, 2025, the Company repaid $15.0 million of the outstanding balance on its revolving credit facility. On August 6, 2025, the Company repaid $7.0 million of the remaining outstanding balance on its revolving credit facility. As a result of the repayment, the outstanding balance on the Company's revolving credit facility has been reduced to $18.0 million. Due to the revolving nature of the credit facility, an additional $47.0 million remains available to the Company to draw upon, should financing be required. Q2 2025 Financial Review (All figures in U.S. dollars, compared to Q2 2024, unless otherwise noted) Total revenue was $13.4 million in Q2 2025, compared to $5.3 million in Q2 2024, an increase of 152% Product revenue from the Canadian product portfolio was $4.1 million in Q2 2025, an increase of 12% from $3.7 million in Q2 2024 Product revenue from Natroba TM in the U.S. was $7.8 million, up sequentially from $6.7 million in Q1 2025 Licensing revenue decreased 9% to $1.5 million in Q2 2025 compared to $1.6 million in Q2 2024, impacted by lower net sales realized by Cipher's partners on which the Company earns a royalty and contractual royalty rate reductions, partially offset by higher product shipments to licensing partners Total gross profit was $10.9 million in Q2 2025, compared to $4.2 million in Q2 2024, an increase of 159% Gross margin as a percentage of product revenue increased by 9% to 79% in Q2 2025 from 70% in Q2 2024, driven by the addition of Natroba™, which was acquired on July 29, 2024 Total gross margin increased by 2% to 81% in Q2 2025 from 79% in Q2 2024 due to the addition of Natroba™, partially offset by reduced licensing revenue Net income and earnings per common share were $5.9 million and $0.23, respectively, in Q2 2025, compared to $3.0 million and $0.12, respectively, in Q2 2024, with the increase primarily attributable to the additional operating income generated from Natroba™ in Q2 2025 EBITDA 1 in Q2 2025 was $8.6 million, compared to $2.2 million in Q2 2024, an increase of 290% Adjusted EBITDA 1 in Q2 2025 was $7.6 million, compared to $3.1 million in Q2 2024, an increase of $4.5 million or 148% Adjusted EBITDA 1 per share in Q2 2025 was $0.29 compared to $0.13 in Q2 2024, an increase of $0.16 per share or 123% Under the Company's NCIB, 230,278 common shares were repurchased and cancelled at an average share price of CDN$12.74 Business Strategy & Outlook Cipher expects to continue to execute on its business strategy, remains focused on profitability and delivering shareholder value. Key areas of focus include: Driving market share growth of Natroba™ in the anti-parasitic market in the U.S. where market leader "Permethrin" is no longer an effective treatment but still holds 75% 2 market share. Obtaining Health Canada regulatory approval for Natroba™ and commercializing the product directly in the Canadian market by leveraging Cipher's existing infrastructure in Canada. Out-licensing Natroba™ globally where there is high unmet need, such as warm climate regions. Acquiring complementary dermatology products to add to our North American platform to enhance the profitability, size and scale of the business. Financial Statements and MD&A Cipher's financial statements for the three and six months ended June 30, 2025, and Management's Discussion and Analysis (the "MD&A") for the three and six months ended June 30, 2025, are available on the Company's website at in the "Investors" section under "Financial Reports" and on SEDAR+ at Notice of Conference Call Cipher will hold a conference call on August 8, 2025 at 8:30 a.m. (ET) to discuss its financial results and other corporate developments. To access the conference call by telephone, dial (416) 945-7677 or (888) 699-1199 A live audio webcast will be available at An archived replay of the webcast will be available until August 15, 2025 and can be accessed by dialing (289) 819-1450 or (888) 660-6345 and entering conference replay code 36094# About Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America. For more information, visit Forward-Looking Statements and Non-IFRS Measures This document includes forward-looking statements within the meaning of applicable securities laws. These forward-looking statements include, among others, expectations for future growth, objectives and goals and strategies to achieve those objectives and goals, the potential purchases to be made under the NCIB, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates and intentions. The words "may", "will", "could", "should", "would", "suspect", "outlook", "believe", "plan", "anticipate", "estimate", "expect", "intend", "forecast", "objective", "hope" and "continue" (or the negative thereof), and words and expressions of similar import, are intended to identify forward-looking statements. By their nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, which give rise to the possibility that predictions, forecasts, projections and other forward-looking statements will not be achieved. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. We caution readers not to place undue reliance on these statements as a number of important factors, many of which are beyond our control, could cause our actual results to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates and intentions expressed in such forward-looking statements. These factors include, but are not limited to, our ability to enter into development, manufacturing and marketing and distribution agreements with other pharmaceutical companies and keep such agreements in effect; our dependency on a limited number of products; our dependency on protection from patents that will expire; the extent and impact of health pandemic outbreaks on our business; integration difficulties and other risks if we acquire or in-license technologies or product candidates; reliance on third parties for the marketing of certain products; the product approval process by regulators which can be highly unpredictable; the timing of completion of clinical trials, regulatory submissions and regulatory approvals; reliance on third parties to manufacture our products and events outside of our control that could adversely impact the ability of our manufacturing partners to supply products to meet our demands; we may be subject to future product liability claims; unexpected product safety or efficacy concerns may arise; we generate license revenue from a limited number of distribution and supply agreements; the Company's performance depends, in part, on the performance of its distributors and suppliers; the pharmaceutical industry is highly competitive with new competing product entrants; requirements for additional capital to fund future operations; products may be subject to pricing regulation; dependence on key managerial personnel and external collaborators; the ability to receive regulatory approvals for products in development or future products; certain of our products are subject to regulation as controlled substances; limitations on reimbursement in the healthcare industry; the ability to convince public payors and hospitals to include our products on the approved formulary lists; ability to receive timely payment from certain customers; application of various laws pertaining to health care fraud and abuse; the Company's reliance on the success of strategic investments and partnerships; the publication of negative results of clinical trials; unpredictable development goals and projected time frames; rising insurance costs; ability to enforce covenants not to compete; risks associated with the healthcare industry generally; we may be unsuccessful in evaluating material risks involved in completed and future acquisitions; we may be unable to identify, acquire or integrate acquisition targets successfully; success in applying tax loss carry forwards; inability to meet covenants under our long-term debt arrangement; compliance with privacy and security regulation; our policies regarding product returns, allowances and chargebacks may reduce revenues; additional regulatory burden and controls over financial reporting; application of regulations that could restrict our activities and abilities to generate revenues as planned; reliance on third parties to perform distribution, logistics, invoicing, regulatory and sales services; general commercial litigation, class actions, other litigation claims and regulatory actions; the difficulty for shareholders to realize in the United States upon judgments of U.S. courts predicated upon civil liability of the Company and its directors and officers who are not residents of the United States; increases in tariffs, trade restrictions or taxes on our products; the potential violation of intellectual property rights of third parties; our efforts to obtain, protect or enforce our patents and other intellectual property rights related to our products; changes in U.S., Canadian or foreign patent laws; inability to protect our trademarks from infringement; shareholders may be further diluted if we issue securities to raise capital; volatility of our share price; the fact that we have a significant shareholder; our operating results may fluctuate significantly; and our debt obligations will have priority over the common shares of the Company in the event of a liquidation, dissolution or winding up. We caution that the foregoing list of important factors that may affect future results is not exhaustive. When reviewing our forward-looking statements, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Additional information about factors that may cause actual results to differ materially from expectations, and about material factors or assumptions applied in making forward-looking statements, may be found in the "Risk Factors" section of our MD&A for the year ended December 31, 2024 and the Company's Annual Information Form, and elsewhere in our filings with Canadian securities regulators. Except as required by Canadian securities law, we do not undertake to update any forward-looking statements, whether written or oral, that may be made from time to time by us or on our behalf; such statements speak only as of the date made. The forward-looking statements included herein are expressly qualified in their entirety by this cautionary language. 1) EBITDA and adjusted EBITDA are non-IFRS financial measures. These non-IFRS measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are unlikely to be comparable to similar measures presented by other companies. Management uses non-IFRS measures such as Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") and Adjusted EBITDA to provide investors with supplemental measures of the Company's operating performance and thus highlight trends in the Company's core business that may not otherwise be apparent when relying solely on IFRS financial measures. The Company defines Adjusted EBITDA as earnings before interest expense, income taxes, depreciation of property and equipment, amortization of intangible assets, non-cash share-based compensation, changes in fair value of derivative financial instruments, costs and provisions for legal matters, loss on disposal of assets and loss on extinguishment of lease, impairment of intangible assets, acquisition costs, restructuring costs, fair value adjustments to acquired inventory and unrealized foreign exchange gains and losses. 2) IQVIA market data as at June 30, 2025. The following is a summary of how EBITDA and Adjusted EBITDA are calculated: (IN THOUSANDS OF U.S. DOLLARS, Three months ended June 30, 2025 Three months ended June 30, 2024 Six months ended June 30, 2025 Six months ended June 30, 2024 except for per share amounts) $ $ $ $ Net income and comprehensive income 5,893 2,995 8,517 7,918 Add back: Depreciation and amortization 1,807 292 3,629 581 Interest expense (income) 345 (611) 815 (1,166) Income tax expense (recovery) 512 (480) (225) (2,435) EBITDA 8,557 2,196 12,736 4,898 Unrealized foreign exchange (gain) loss (1,759) 401 (1,770) 1,043 Acquisition, restructuring and other costs — 284 128 284 Fair value adjustments to acquired inventory 131 — 777 — Costs and provisions for legal matter 221 — 1,221 — Share-based compensation 436 183 680 407 Adjusted EBITDA 7,586 3,064 13,772 6,632 Adjusted EBITDA per share – basic 0.29 0.13 0.54 0.28 Adjusted EBITDA per share – dilutive 0.29 0.12 0.52 0.27 Consolidated statements of income and comprehensive income Three months ended June 30, Six months ended June 30, (IN THOUSANDS OF U.S. DOLLARS, 2025 2024 2025 2024 except for per share amounts) $ $ $ $ Revenue Licensing revenue 1,478 1,618 2,213 4,218 Product revenue 11,903 3,686 23,187 6,953 Net revenue 13,381 5,304 25,400 11,171 Operating expenses Cost of products sold 2,498 1,106 5,377 2,161 Research and development — — 21 — Depreciation and amortization 1,807 292 3,629 581 Selling, general and administrative 4,085 1,601 9,036 3,069 Total operating expenses 8,390 2,999 18,063 5,811 Other (income) expenses Interest expense (income) 345 (611) 815 (1,166) Unrealized foreign exchange (gain) loss (1,759) 401 (1,770) 1,043 Total other (income) expenses (1,414) (210) (955) (123) Income before income taxes 6,405 2,515 8,292 5,483 Current income tax expense — — — — Deferred income tax expense (recovery) 512 (480) (225) (2,435) Total income tax expense (recovery) 512 (480) (225) (2,435) Net income and comprehensive income for the period 5,893 2,995 8,517 7,918 Income per share Basic 0.23 0.12 0.33 0.33 Diluted 0.22 0.12 0.32 0.32 Consolidated statements of financial position As at June 30, As at December 31, 2025 2024 (IN THOUSANDS OF U.S. DOLLARS) $ $ Assets Current assets Cash and cash equivalents 11,339 17,837 Accounts receivable 11,868 13,860 Inventory 5,576 5,792 Prepaid expenses and other assets 1,766 995 Total current assets 30,549 38,484 Property and equipment 522 680 Intangible assets 75,287 78,754 Deferred financing costs 311 386 Goodwill 17,447 17,447 Deferred tax assets 28,278 26,761 Total assets 152,394 162,512 Liabilities and shareholders' equity Current liabilities Accounts payable and accrued liabilities 4,846 5,873 Income taxes payable 9 54 Interest payable 82 358 Contract liabilities 12,564 13,306 Current portion of lease obligation 262 283 Total current liabilities 17,763 19,874 Lease obligation 193 295 Long-term debt 25,000 40,000 Total liabilities 42,956 60,169 Shareholders' equity Share capital 27,556 27,680 Contributed surplus 7,149 6,525 Accumulated other comprehensive loss (9,514) (9,514) Retained earnings 84,247 77,652 Total shareholders' equity 109,438 102,343 Total liabilities and shareholders' equity 152,394 162,512 SOURCE Cipher Pharmaceuticals Inc.
Cision Canada
5 hours ago
- Cision Canada
CES ENERGY SOLUTIONS CORP. ANNOUNCES STRONG Q2 2025 RESULTS WITH RECORD SECOND QUARTER REVENUE AND DECLARES CASH DIVIDEND
CALGARY, AB, Aug. 7, 2025 /CNW/ - CES Energy Solutions Corp. ("CES" or the "Company") (TSX: CEU) (OTC: CESDF) is pleased to announce strong financial results for the three and six months ended June 30, 2025. The Company's Board of Directors also approved a quarterly dividend of $0.0425 per share, which will be paid on October 15, 2025, to the shareholders of record at the close of business on September 30, 2025. Record second quarter revenue of $574.0 million, increased 4% year over year Quarterly Adjusted EBITDAC of $88.3 million at a 15.4% margin Maintained conservative leverage of 1.25x Total Debt/Adjusted EBITDAC Returned $40.9 million to shareholders through $9.5 million in dividends and $31.3 million for the repurchase of 4.8 million shares, representing approximately 2.2% of common shares outstanding at April 1, 2025 CES' second quarter results continue to demonstrate the significant merits of its unique business model. CES has continued to provide mission critical chemical solutions enabling our customers to succeed in an era of high service intensity levels, and increasingly complex drilling fluids and production chemical technology requirements. CES' performance is characterized by strong levels of financial resilience, cash flow generation, and profitability inherent in its capex light, asset light, vertically integrated consumable chemicals business model supported by industry leading people, infrastructure, and technology. CES continues to provide valuable solutions to increasingly complicated drilling programs which require higher levels of service intensity, effectively overcoming lower US and Canadian rig counts. Attractive revenue growth was also achieved by delivering superior production chemical services and technology to active, results oriented, high quality customers as they continue to maximize returns on their producing wells through effective chemical treatments. CES remains confident in its ability to continue generating strong surplus free cash flow, supported by its financial performance, outlook, and capital structure, and furthermore, on August 7, 2025, the Company's Board of Directors approved a quarterly dividend of $0.0425 per share, which will be paid on October 15, 2025, to the shareholders of record at the close of business on September 30, 2025. Second Quarter Results Revenue in the quarter was a second quarter record at $574.0 million, representing a sequential decrease of $58.4 million or 9% compared to $632.4 million in Q1 2025, on seasonally lower activity levels in Canada, and an increase of $20.8 million or 4% compared to $553.2 million in Q2 2024. For the six months ended June 30, 2025, CES generated revenue of $1.2 billion, an increase of $64.6 million or 6% relative to the six months ended June 30, 2024. The increases over prior year comparative periods are driven by strong market share positions and continued strength in service intensity, resulting in an overall uptick in revenue despite softening industry rig counts in both the US and Canada. Revenue generated in the US during Q2 2025 set a new quarterly record at $405.6 million, representing a sequential increase of $3.1 million or 1% compared to Q1 2025, and an increase of $14.6 million or 4% compared to Q2 2024. For the six months ended June 30, 2025, revenue generated in the US was up 4% to $808.0 million relative to the six months ended June 30, 2024. US revenues for both the three and six month periods benefited from strengthened market positioning, achieving record US Drilling Fluids Market Share of 25% and 24% for the three and six months ended June 30, 2025, respectively, compared to 22% for both the three and six months ended June 30, 2024. Revenue generated in Canada during Q2 2025 was a second quarter record at $168.4 million, representing a sequential decrease of $61.6 million or 27% compared to Q1 2025 as is expected on a seasonal basis given the 40% decline in industry rig count relative to Q1 2025, and an increase of $6.2 million or 4% compared to Q2 2024. For the six months ended June 30, 2025, revenue generated in Canada was up 10% to $398.4 million relative to the six months ended June 30, 2024. Canadian revenues for both the three and six month periods benefited from strong market share and higher service intensity year over year despite negative impacts from forest fires and customer plant turnarounds in the current period. Canadian Drilling Fluids Market Share of 36% and 40% for the three and six months ended June 30, 2025, respectively, compared to 31% and 33% for the three and six months ended June 30, 2024, respectively. CES achieved Adjusted EBITDAC of $88.3 million, representing a decrease of 12% compared to Q1 2025, reflective of seasonally lower activity levels in Canada, and 8% compared to Q2 2024. Adjusted EBITDAC as a percentage of revenue of 15.4% in Q2 2025 compared with 15.8% in Q1 2025 and 17.3% in Q2 2024. For the six months ended June 30, 2025, Adjusted EBITDAC decreased 5% to $188.2 million from $197.5 million in the six months ended June 30, 2024. Adjusted EBITDAC for both the three and six months ended was impacted by personnel investments to support new business initiatives, the impacts of the Canadian forest fires, and a less favorable product mix. Net income for the three months ended June 30, 2025, increased 8% to $51.8 million, relative to the comparable period of 2024. The increase was driven by a higher stock-based compensation expense in the prior year period associated with the appreciation in the Company's share price. Net income for the six months ended June 30, 2025, decreased 7% to $95.9 million relative to the prior year comparative period. The decrease was driven by higher finance costs associated with the impact of the Company's equity derivative contracts, partially offset by foreign exchange gain and record revenue levels. During the quarter, CES returned $40.9 million to shareholders (Q2 2024 - $7.0 million), through $31.3 million in shares repurchased under its NCIB and its quarterly dividend of $9.5 million (Q2 2024 - nil and $7.0 million, respectively). For the six months ended June 30, 2025, CES returned $68.9 million to shareholders (2024 - $30.7 million), through $52.6 million in shares repurchased under its NCIB and its quarterly dividends of $16.3 million (2024 - $17.8 million and $12.9 million, respectively). CES generated $76.7 million in Funds Flow from Operations in Q2 2025, compared to $77.8 million generated in Q1 2025 and $61.6 million generated in Q2 2024. For the six months ended June 30, 2025, CES generated $154.5 million of Funds Flow from Operations compared to $135.7 million in 2024. Funds Flow from Operations excludes the impact of working capital, and is reflective of the continued strong surplus free cash flow generated in Q2 2025. For Q2 2025, net cash provided by operating activities totaled $66.0 million compared to $83.2 million during the three months ended June 30, 2024. For the six months ended June 30, 2025, net cash provided by operating activities of $126.1 million compared to $169.6 million for the six months ended June 30, 2024. The decrease in net cash provided by operating activities for the three and six month periods was driven by an increase to working capital requirements to support record revenue levels when compared to the prior year. CES generated $35.3 million in Free Cash Flow in Q2 2025, compared to $25.6 million generated in Q1 2025, and $54.8 million generated in Q2 2024. For the six months ended June 30, 2025, CES generated $60.9 million of Free Cash Flow compared to $112.2 million in 2024. The year over year decrease in both the three and six month periods was driven by elevated working capital requirements to support record revenue levels and increased lease repayments. Free Cash Flow includes the impact of quarterly working capital variations, net of capital expenditures, and lease repayments. As at June 30, 2025, CES had a Working Capital Surplus of $671.6 million, which decreased from $686.8 million at March 31, 2025, and $681.1 million at December 31, 2024. The movement during the quarter was driven by decreases to Accounts Receivable and Accounts Payable and Accrued Liabilities in line with the sequential decrease in revenue. The Company continues to focus on working capital optimization benefiting from the high quality of its customers and diligent internal credit monitoring processes. On April 28, 2025, CES entered into an amended and restated credit agreement with respect to its syndicated and operating credit facilities (the "Senior Facility"). The total size of the Senior Facility is approximately C$550.0 million, representing a $100.0 million increase from the prior Senior Facility of C$450.0 million. The Senior Facility matures on November 24, 2028, and is secured by substantially all of the Company's assets and includes customary terms, conditions and covenants. As at June 30, 2025, CES had Total Debt of $490.9 million compared to $469.2 million at March 31, 2025, and $452.6 million at December 31, 2024. Included in Total Debt at June 30, 2025, is the Senior Facility of $177.3 million (December 31, 2024 - $148.8 million), $200.0 million of Senior Notes (December 31, 2024 - $200.0 million), and lease obligations of $96.7 million (December 31, 2024 - $91.9 million). The increase in Total Debt during the period was driven by elevated shareholder returns and the strategic tuck-in acquisition of Fossil Fluids LLC, partially offset by continued strong financial performance. Working Capital Surplus exceeded Total Debt at June 30, 2025, by $180.7 million (December 31, 2024 - $228.5 million). As of the date of this press release, the Company had total long-term debt of approximately $368.0 million, comprised of a net draw on its Senior Facility of approximately $168.0 million and its outstanding $200.0 million Senior Notes due May 24, 2029. On June 1, 2025, CES closed the acquisition of substantially all of the business assets of Fossil Fluids LLC. ("Fossil Fluids"). Fossil Fluids provides independent drilling fluids solutions for the upstream oil and gas industry, with a focus on servicing the Mid-Continent region. Operating under AES Drilling Fluids, the acquisition augments the Company's regional operations and will be enhanced by CES' advanced technology and supply chain capabilities, extensive customer reach in its North American platform, and vertically integrated business model. The aggregate purchase price was $14.2 million consisting of $7.0 million in up front cash consideration and $7.2 million in deferred consideration, which is payable in cash as an earn-out upon achieving certain EBITDA thresholds over a three-year period post close. Outlook The demand trends of developing countries and global demand requirements to support eventual energy transition initiatives, combined with depletion of existing resources, reduced investment in the upstream oil and gas sector over recent years, and diminished available inventory quality, has necessitated increased service intensity for available resources. The result is a continuation of constructive end markets for CES' products and services which enhance drilling and production performance. Economic uncertainty, OPEC+ easing of production cuts, and ongoing global conflicts have tempered near-term energy supply-demand dynamics. Despite this, energy demand has continued to be resilient and industry fundamentals continue to support critical drilling and production activity for oil and natural gas as current depressed global inventories and fewer high-quality drilling locations provide cautious optimism for suitable pricing over the mid to longer term. In the shorter term the situation is more fluid as customers are closely monitoring fluctuating oil and gas pricing in the context of their inherent production economics which may impact activity levels, spending plans, and, by extension, product pricing. While the current political landscape and impact of recently imposed tariffs in both the US and Canada continues to generate potential uncertainty, including within the energy sector, CES' business model provides relative protection due to its significant proportion of revenue derived in the US versus Canada, its vertically integrated business models in both countries, and flexible supply chain capabilities. CES expects to benefit from secular trends in upstream activity, increased service intensity levels, and adoption of advanced critical chemical solutions by capitalizing on its established infrastructure, industry leading positioning, vertically integrated business model, and strategic procurement practices. Commensurate with current record revenue levels, CES expects 2025 capital expenditures, net of proceeds on disposals of assets, to be approximately $80.0 million, evenly weighted between maintenance and expansion capital to support sustained activity levels and business development opportunities. CES plans to continue its disciplined and prudent approach to capital expenditures and will adjust its plans as required to support prudent growth initiatives throughout divisions. CES has proactively managed both the duration and the flexibility of its debt. In May 2024, CES successfully issued $200.0 million of Senior Notes due May 24, 2029, and in April 2025, CES amended, extended, and upsized its Senior Facility, with improved terms and a maturity extension until November 2028. The combination of the Senior Notes and the Senior Facility further strengthens the Company's capital structure, reduces the cost of capital, and effectively addresses CES' near-term and foreseeable longer-term requirements. CES routinely considers its capital structure, including increasing or decreasing the capacity of its Senior Facility, issuance or redemption of Senior Notes, and other potential financing options. CES' underlying business model is capex light and asset light, enabling the generation of significant surplus free cash flow. As our customers endeavor to maintain or grow production in the current environment, CES will leverage its established infrastructure, business model, and nimble customer-oriented culture to deliver superior products and services to the industry. CES sees the consumable chemical market increasing its share of the oilfield spend as operators continue to: drill longer reach laterals and drill them faster; expand and optimize the utilization of pad drilling; increase the intensity and size of their fracs; and require increasingly technical and specialized chemical treatments to effectively maintain existing cash flow generating wells and treat growing production volumes and water cuts from new wells. Conference Call Details With respect to the second quarter results, CES will host a conference call / webcast at 9:00 am MT (11:00 am ET) on Friday, August 8, 2025. The Link to Webcast and Dial-In information can be found at A recording of the live audio webcast of the conference call will also be available on our website at The webcast will be archived for approximately 90 days. Financial Highlights Three Months Ended June 30, Six Months Ended June 30, 2025 2024 % Change 2025 2024 % Change Revenue United States (1) 405,557 390,924 4 % 808,018 778,598 4 % Canada (1) 168,434 162,272 4 % 398,404 363,176 10 % Total Revenue 573,991 553,196 4 % 1,206,422 1,141,774 6 % Net income 51,834 48,155 8 % 95,936 102,613 (7) % per share – basic 0.23 0.20 15 % 0.43 0.44 (2) % per share - diluted 0.23 0.20 15 % 0.42 0.43 (2) % Adjusted EBITDAC (2) 88,253 95,447 (8) % 188,151 197,479 (5) % Adjusted EBITDAC (2) % of Revenue 15.4 % 17.3 % (1.9) % 15.6 % 17.3 % (1.7) % Funds Flow from Operations (2) 76,650 61,560 25 % 154,469 135,725 14 % Change in non-cash working capital (10,656) 21,685 (149) % (28,384) 33,848 (184) % Cash provided by (used in) operating activities 65,994 83,245 (21) % 126,085 169,573 (26) % Free Cash Flow (2) 35,282 54,837 (36) % 60,882 112,207 (46) % Capital expenditures Expansion Capital (1) 15,167 15,357 (1) % 31,304 32,441 (4) % Maintenance Capital (1) 6,268 6,289 — % 19,560 11,751 66 % Total capital expenditures 21,435 21,646 (1) % 50,863 44,192 15 % Dividends declared 9,347 7,056 32 % 18,882 14,092 34 % per share 0.0425 0.0300 42 % 0.0850 0.0600 42 % Common Shares Outstanding End of period - basic 219,940,242 235,188,873 219,940,242 235,188,873 End of period - fully diluted (2) 222,588,862 239,430,548 222,588,862 239,430,548 Weighted average - basic 221,616,603 235,162,870 223,328,099 234,768,108 Weighted average - diluted 224,261,923 239,402,896 226,297,066 239,407,658 As at Financial Position June 30, 2025 March 31, 2025 % Change December 31, 2024 % Change Total assets 1,535,044 1,593,828 (4) % 1,539,331 — % Long-term debt 373,917 354,038 6 % 344,888 8 % Long-term financial liabilities (3) 447,406 427,440 5 % 412,608 8 % Total Debt (2) 490,928 469,233 5 % 452,588 8 % Working Capital Surplus (2) 671,604 686,763 (2) % 681,085 (1) % Net Debt (2) (180,676) (217,530) (17) % (228,497) (21) % Shareholders' equity 789,587 828,884 (5) % 814,230 (3) % 1 Supplementary Financial Measure. Supplementary Financial Measures are provided herein because Management believes they assist the reader in understanding CES' results. Refer to "Non-GAAP Measures and Other Financial Measures" contained herein. 2 Non-GAAP measure that does not have any standardized meaning under IFRS ® Accounting Standards as issued by the International Accounting Standards Board ("IASB") and therefore may not be comparable to similar measures presented by other entities. The most directly comparable GAAP measure for Adjusted EBITDAC is Net income, for Funds Flow from Operations and Free Cash flow is Cash provided by (used in) operating activities, for Shares Outstanding, End of period - fully diluted is Common Shares outstanding, and for Total Debt, Net Debt, and Working Capital Surplus is Long-term financial liabilities. Refer to the section entitled "Non-GAAP Measures and Other Financial Measures" contained herein. 3 Includes long-term portion of the Senior Facility, the Senior Notes, lease obligations, deferred acquisition consideration, and cash settled incentive obligations. Business of CES CES is a leading provider of technically advanced consumable chemical solutions throughout the life-cycle of the oilfield. This includes total solutions at the drill-bit, at the point of completion and stimulation, at the wellhead and pump-jack, and finally through to the pipeline and midstream market. Key solutions include corrosion inhibitors, demulsifiers, H2S scavengers, paraffin control products, surfactants, scale inhibitors, biocides and other specialty products. Further, specialty chemicals are used throughout the pipeline and midstream industry to aid in hydrocarbon movement and manage transportation and processing challenges including corrosion, wax build-up and H2S. CES operates in all major basins throughout the United States ("US"), including the Permian, Eagleford, Bakken, Marcellus and Scoop/Stack, as well as in the Western Canadian Sedimentary Basin ("WCSB") with an emphasis on servicing the ongoing major resource plays: Montney, Duvernay, Deep Basin and SAGD. In the US, CES operates under the trade names AES Drilling Fluids ("AES"), AES Completion Services, Jacam Catalyst LLC ("Jacam Catalyst"), and Superior Weighting Products ("Superior Weighting"). In Canada, CES operates under the trade names Canadian Energy Services, CES Completion Services, PureChem Services ("PureChem"), StimWrx Energy ("StimWrx"), Sialco Materials ("Sialco"), and Clear Environmental Solutions ("Clear"). Non-GAAP Measures and Other Financial Measures CES uses certain supplementary information and measures not recognized under IFRS where management believes they assist the reader in understanding CES' results. These measures are calculated by CES on a consistent basis unless otherwise specifically explained. These measures do not have a standardized meaning under IFRS and may therefore not be comparable to similar measures used by other issuers. Non-GAAP financial measures and non-GAAP ratios have the definition set out in National Instrument 52-112 "Non-GAAP and Other Financial Measures Disclosure". The non-GAAP measures, non-GAAP ratios and supplementary financial measures used herein, with IFRS measures, are the most appropriate measures for reviewing and understanding the Company's financial results. The non-GAAP measures and non-GAAP ratios are further defined as follows: EBITDAC - is a non-GAAP measure that has been reconciled to net income for the financial periods, being the most directly comparable measure calculated in accordance with IFRS. EBITDAC is defined as net income before interest, taxes, depreciation and amortization, finance costs, other income (loss), stock-based compensation, and impairment of goodwill, which are not reflective of underlying operations. EBITDAC is a metric used to assess the financial performance of an entity's operations. Management believes that this metric provides an indication of the results generated by the Company's business activities prior to how these activities are financed, how the Company is taxed in various jurisdictions, and how the results are impacted by foreign exchange and non-cash charges. This non-GAAP financial measure is also used by Management as a key performance metric supporting decision making and assessing divisional results. Adjusted EBITDAC - is a non-GAAP measure that is defined as EBITDAC noted above, adjusted for specific items that are considered to be non-recurring in nature. Management believes that this metric is relevant when assessing normalized operating performance. Adjusted EBITDAC % of Revenue - is a non-GAAP ratio calculated as Adjusted EBITDAC divided by revenue. Management believes that this metric is a useful measure of the Company's normalized operating performance relative to its top line revenue generation and a key industry performance measure. Readers are cautioned that EBITDAC and Adjusted EBITDAC should not be considered to be more meaningful than net income determined in accordance with IFRS. EBITDAC, Adjusted EBITDAC, and Adjusted EBITDAC % of Revenue are calculated as follows: Distributable Earnings - is a non-GAAP measure that is defined as cash provided by operating activities, adjusted for change in non-cash operating working capital less Maintenance Capital and repayment of lease obligations. Distributable Earnings is a measure used by Management and investors to analyze the amount of funds available to distribute to shareholders as dividends or through the NCIB program before consideration of funds required for growth purposes. Dividend Payout Ratio - is a non-GAAP ratio that is defined as dividends declared as a percentage of Distributable Earnings. Management believes it is a useful measure of the proportion of available funds committed to being returned to shareholders in the form of a dividend relative to the Company's total Distributable Earnings. Readers are cautioned that Distributable Earnings should not be considered to be more meaningful than cash provided by operating activities determined in accordance with IFRS. Distributable Earnings and Dividend Payout Ratio are calculated as follows: 1 Supplementary Financial Measure. Supplementary Financial Measures are provided herein because Management believes they assist the reader in understanding CES' results. Funds Flow From Operations - is a non-GAAP measure that has been reconciled to Cash provided by (used in) operating activities for the financial periods, being the most directly comparable measure calculated in accordance with IFRS. Funds Flow from Operations is defined as cash flow from operations before changes in non-cash operating working capital and represents the Company's after-tax operating cash flows. Readers are cautioned that this measure is not intended to be considered more meaningful than cash provided by operating activities, or other measures of financial performance calculated in accordance with IFRS. Funds Flow from Operations is used by Management to assess operating performance and leverage, and is calculated as follows: Free Cash Flow - is a non-GAAP measure that has been reconciled to Cash provided by (used in) operating activities for the financial periods, being the most directly comparable measure calculated in accordance with IFRS. Free Cash Flow is defined as cash flow from operations adjusted for capital expenditures and repayment of lease obligations, net of proceeds on disposal of assets, and represents the Company's core operating results in excess of required capital expenditures. Readers are cautioned that this measure is not intended to be considered more meaningful than cash provided by operating activities, or other measures of financial performance calculated in accordance with IFRS. Free Cash Flow is used by Management to assess operating performance and leverage, and is calculated as follows: 1 Supplementary Financial Measure. Supplementary Financial Measures are provided herein because Management believes they assist the reader in understanding CES' results. Net Cash Used for Investment in Property and Equipment - is a non-GAAP measure that has been reconciled to Cash used for investment in property and equipment, being the most directly comparable measure calculated in accordance with IFRS. Management believes that this metric is a key measure to assess the total capital required to support ongoing business operations. Readers are cautioned that this measure is not intended to be considered more meaningful than cash used for investment in property and equipment or other measures of financial performance calculated in accordance with IFRS. Net Cash Used for Investment in Property and Equipment is calculated as follows: Working Capital Surplus - is a non-GAAP measure that is calculated as current assets less current liabilities, excluding the current portion of finance lease obligations, current portion of long-term debt, and deferred acquisition consideration. Management believes that this metric is a key measure to assess operating performance and leverage of the Company and uses it to monitor its capital structure. Net Debt and Total Debt - are non-GAAP measures that Management believes are key metrics to assess liquidity of the Company and uses them to monitor its capital structure. Net Debt represents Total Debt, which includes the Senior Facility, The Canadian Term Loan Facility, the Senior Notes, both current and non-current portions of lease obligations, both current and non-current portions of deferred acquisition consideration, non-current portion of cash settled incentive obligations, offset by the Company's cash position, less Working Capital Surplus. Readers are cautioned that Total Debt, Working Capital Surplus, and Net Debt should not be construed as alternative measures to Long-term financial liabilities determined in accordance with IFRS. Total Debt, Working Capital Surplus, and Net Debt are calculated as follows: 1 Includes long-term portion of the Senior Facility, the Canadian Term Loan Facility, the Senior Notes, lease obligations, deferred acquisition consideration, and long-term portion of cash settled incentive obligations. 2 Excludes current portion of lease liabilities, long-term debt and deferred acquisition consideration. Total Debt/Adjusted EBITDAC – is a non-GAAP ratio that Management believes to be a useful measure of the Company's liquidity and leverage levels, and is calculated as Total Debt divided by Adjusted EBITDAC for the most recently ended four quarters. Total Debt and Adjusted EBITDAC are non-GAAP measures that do not have any standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other entities. Total Debt and Adjusted EBITDAC are calculated as outlined above. Shares outstanding, End of period - fully diluted - is a non-GAAP measure that has been reconciled to Common Shares outstanding for the financial periods, being the most directly comparable measure calculated in accordance with IFRS. This measure is not intended to be considered more meaningful than Common shares outstanding. Management believes that this metric is a key measure to assess the total potential shares outstanding for the financial periods and is calculated as follows: Supplementary Financial Measures A Supplementary Financial Measure: (a) is, or is intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company; (b) is not presented in the financial statements of the Company; (c) is not a non-GAAP financial measure; and (d) is not a non-GAAP ratio. Supplementary financial measures found within this press release are as follows: Revenue - United States - comprises a component of total revenue, as determined in accordance with IFRS, and is calculated as revenue recorded from the Company's US divisions. Revenue - Canada - comprises a component of total revenue, as determined in accordance with IFRS, and is calculated as revenue recorded from the Company's Canadian divisions. Expansion Capital - comprises a component of total investment in property and equipment as determined in accordance with IFRS, and represents the amount of capital expenditure that has been or will be incurred to grow or expand the business or would otherwise improve the productive capacity of the operations of the business. Maintenance Capital - comprises a component of total investment in property and equipment as determined in accordance with IFRS, and represents the amount of capital expenditure that has been or will be incurred to sustain the current level of operations. Cautionary Statement Except for the historical and present factual information contained herein, the matters set forth in this press release, may constitute forward-looking information or forward-looking statements (collectively referred to as "forward-looking information") which involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of CES, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information. When used in this press release, such information uses such words as "may", "would", "could", "will", "intend", "expect", "believe", "plan", "anticipate", "estimate", and other similar terminology. This information reflects CES' current expectations regarding future events and operating performance and speaks only as of the date of the press release. Forward-looking information involves significant risks and uncertainties, should not be read as a guarantee of future performance or results, and will not necessarily be an accurate indication of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking information, including, but not limited to, the factors discussed below. The management of CES believes the material factors, expectations and assumptions reflected in the forward-looking information are reasonable but no assurance can be given that these factors, expectations and assumptions will prove to be correct. The forward-looking information contained in this document speaks only as of the date of the document, and CES assumes no obligation to publicly update or revise such information to reflect new events or circumstances, except as may be required pursuant to applicable securities laws or regulations. The material assumptions in making forward-looking statements include, but are not limited to, assumptions relating to demand levels and pricing for the oilfield consumable chemical offerings of the Company; fluctuations in the price and demand for oil and natural gas; anticipated activity levels of the Company's significant customers; commodity pricing; general economic and financial market conditions; the successful integration of recent acquisitions; the Company's ability to finance its operations; levels of drilling and other activity in the WCSB, the Permian and other US basins, the effects of seasonal and weather conditions on operations and facilities; changes in laws or regulations; currency exchange fluctuations; the ability of the Company to attract and retain skilled labour and qualified management; and other unforeseen conditions which could impact the Company's business of supplying oilfield consumable chemistry to the Canadian and US markets and the Company's ability to respond to such conditions. In particular, this press release contains forward-looking information pertaining to the following: the certainty and predictability of future cash flows, profitability and earnings; expectations regarding CES' revenue and surplus free cash flow generation and the potential use of such free cash flow including to pay its dividend or repurchase the common shares of the Company; expectations regarding end market activity levels; the strength of the Company's balance sheet, the achievement of the Company's strategic objectives, and the generation of shareholder value; expectations regarding industry conditions; CES' ability to execute on financial goals relating to its balance sheet, liquidity, working capital and cost structure; the sufficiency of liquidity and capital resources to meet long-term payment obligations; CES' ability to increase or maintain its market share; optimism with respect to future prospects for CES; impact of CES' vertically integrated business model on future financial performance; supply and demand for CES' products and services, including expectations for growth in CES' production and specialty chemical sales, expected growth in the consumable chemicals market; industry activity levels; expectations regarding the impact of economic policy and tariffs on the energy sector, supply chains, the Company, including the degree of impact to the Company; expectations regarding service intensity in the upstream oil and gas sector; expectations regarding the adoption of advanced critical chemical solutions; inherent production economics; oil and gas inventory levels; reduced availability of high quality drilling locations; expectations regarding OPEC+ production quotas; anticipated drilling activity for natural gas projects; development of new technologies; expectations regarding CES' growth opportunities in Canada the US and overseas; expectations regarding the performance or expansion of CES' operations and working capital optimization; expectations relating to general economic conditions, interest rates and geopolitical risk; expectations regarding end markets for production chemicals and drilling fluids in Canada and the US; expectations regarding demand for CES' services and technology; access to debt and capital markets and cost of capital; impacts of the Company's issuance of Senior Notes on the Company's capital structure and reduced cost of capital; expectations regarding capital allocation including the use of surplus free cash flow, debt reduction through the repayment of the Company's Senior Facility; investments in current operations, issuing dividends, or market acquisitions; expectations regarding the timing and amount of common shares repurchased pursuant to the Company's NCIB; CES' ability to continue to comply with covenants in debt facilities; and competitive conditions. CES' actual results could differ materially from those anticipated in the forward-looking information as a result of the following factors: general economic conditions in the US, Canada, and internationally; geopolitical risk; fluctuations in demand for consumable fluids and chemical oilfield services, downturn in oilfield activity; oilfield activity in the Permian, the WCSB, and other basins in which the Company operates; a decline in frac related chemical sales; a decline in operator usage of chemicals on wells; decreased service intensity levels; an increase in the number of customer well shut-ins; a shift in types of wells drilled; volatility in market prices for oil, natural gas, and natural gas liquids and the effect of this volatility on the demand for oilfield services generally; declines in prices for natural gas, natural gas liquids, and oil, and pricing differentials between world pricing, pricing in North America, and pricing in Canada; decisions by OPEC+ regarding production quotas; the impact of the removal of sanctions on Russia and the potential for additional oil and gas supply to global markets; competition, and pricing pressures from customers in the current commodity environment; conflict, war and political and societal unrest that may impact CES' operations, supply chains as well as impact the market for oil and natural gas generally; currency risk as a result of fluctuations in value of the US or Canadian dollar; liabilities and risks, including environmental liabilities and risks inherent in oil and natural gas operations; sourcing, pricing and availability of raw materials, consumables, component parts, equipment, suppliers, facilities, shipping containers, and skilled management, technical and field personnel; the collectability of accounts receivable; ability to integrate technological advances and match advances of competitors; ability to protect the Company's proprietary technologies; availability of capital; uncertainties in weather and temperature affecting the duration of the oilfield service periods and the activities that can be completed; the ability to successfully integrate and achieve synergies from the Company's acquisitions; changes in legislation and the regulatory environment, including uncertainties with respect to oil and gas royalty regimes, programs to reduce greenhouse gas and other emissions and regulations restricting the use of hydraulic fracturing; pipeline capacity and other transportation infrastructure constraints; changes to government mandated production curtailments; reassessment and audit risk and other tax filing matters; changes and proposed changes to US policies including tax policies, policies relating to the oil and gas industry, or trade policies; impact of tariffs on the global economy, supply chains, the energy industry, and the Company; international and domestic trade disputes, including restrictions on the transportation of oil and natural gas and regulations governing the sale and export of oil, natural gas and refined petroleum products; the impact of climate change policies in the regions which CES operates; the impact and speed of adoption of low carbon technologies; potential changes to the crude by rail industry; changes to the fiscal regimes applicable to entities operating in the US and WCSB; access to capital and the liquidity of debt markets; fluctuations in foreign exchange and interest rates, including the impact of changing interest rates on the broader economy; CES' ability to maintain adequate insurance at rates it considers reasonable and commercially justifiable; and the other factors considered under "Risk Factors" in CES' Annual Information Form for the year ended December 31, 2024, dated March 6, 2025, and "Risks and Uncertainties" in CES' MD&A for the three and six months ended June 30, 2025, dated August 7, 2025. SOURCE CES Energy Solutions Corp.
Cision Canada
10 hours ago
- Cision Canada
FP Canada™ Announces June CFP® Exam and QAFP® Exam Results
Of the first-time writers who completed the CFP exam, 81% passed. Seventy-five per cent of first-time QAFP exam writers passed. TORONTO, Aug. 7, 2025 /CNW/ - FP Canada has announced the results for the June sittings of the Certified Financial Planner ® exam and the Qualified Associate Financial Planner ™ exam. There were 385 candidates who wrote the CFP exam (and 81% of the first-time writers passed), while 50 candidates wrote the QAFP exam (and the first-time writer pass rate was 75%). FP Canada administered a survey to all candidates who wrote the exams. According to that survey, 82% of CFP exam writers decided to pursue certification so they could enhance their skills and better serve their clients. The same was true for 76% of candidates pursing QAFP certification. Forty-nine per cent of CFP candidates and 48% of QAFP candidates indicated that provincial legislation requiring them to obtain an approved certification to use the "financial planner" title was a major motivator. Likewise, 30% of CFP exam writers and 24% of those who wrote the QAFP exam stated that their pursuit of certification was driven largely by an employer requirement. "We at FP Canada would like to sincerely congratulate everyone who successfully wrote the CFP exam or QAFP exam in June," says Tashia Batstone, President and CEO of FP Canada. "Completing this critical step toward certification is a tremendous accomplishment—one that brings you closer to being fully qualified to help Canadians find their paths to financial well-being." To obtain CFP certification, candidates must complete a comprehensive education program that includes professional education, pass a national exam, have (at minimum) a bachelor's degree or 10 years of qualifying work experience (or have held QAFP certification for at least five years), and demonstrate three years of qualifying work experience. QAFP certification candidates must complete a comprehensive education program, pass a national exam, have a post-secondary diploma or five years of qualifying work experience, and demonstrate one year of qualifying work experience. To maintain certification, CFP professionals must ensure their knowledge and skills remain current by completing 25 hours of continuing education each year, including two hours in the professional responsibility category. QAFP professionals must complete 12 hours of continuing education each year, including one hour in the professional responsibility category. CFP professionals and QAFP professionals must also adhere to high professional standards established by the FP Canada Standards Council ™. CFP certification and QAFP certification have been approved by the Financial Services Regulatory Authority of Ontario (FSRA) as valid credentials for individuals using the "financial planner" title in Ontario. Established in 1995, FP Canada is a national not-for-profit education, certification and professional oversight organization working in the public interest. FP Canada is dedicated to championing better financial wellness for all Canadians by leading the advancement of professional financial planning in Canada.
